An Open-label, Dose-finding Study to Evaluate the Safety of AMG 706 in Combination With Paclitaxel or Docetaxel as Treatment for Locally Recurrent or Metastatic Breast Cancer.

Trial Profile

An Open-label, Dose-finding Study to Evaluate the Safety of AMG 706 in Combination With Paclitaxel or Docetaxel as Treatment for Locally Recurrent or Metastatic Breast Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Jul 2013

At a glance

  • Drugs Motesanib (Primary) ; Docetaxel; Paclitaxel
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Biomarker; Pharmacogenomic
  • Sponsors Amgen
  • Most Recent Events

    • 01 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Oct 2008 Added actual number of patients, based on information from ClinicalTrials.gov.
    • 30 Oct 2008 Status changed from recruiting to active, no longer recruiting, based on information from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top